Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

House-passed opioid abatement bill (H 218) draws committee scrutiny over appropriations and governance

3004761 · April 16, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Senate Health & Welfare reviewed H 218, the house-passed opioid abatement appropriation bill, including roughly $9.8–$9.9 million in FY26 awards and changes to advisory-committee governance and statutory terminology.

Senate Health & Welfare members examined H 218, the house-passed bill that centralizes opioid abatement appropriations into a single bill and adds policy changes for how the special fund is governed and monitored.

Teresa Wood, chair of House Human Services and a presenter on the bill, told the committee that Human Services worked to align the recommendations of the opioid abatement advisory committee and the Department of Health: “House Human Services really took great pains ... to avoid deviating from the recommendations of the opioid advisory settlement committee.” The administration asked that the special-fund appropriations be consolidated into a single bill for clarity.

Nolan (fiscal office) walked the committee through the fiscal note: the house version of H 218 appropriates roughly $9.8–$9.9 million for fiscal year 2026, and includes several line items…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans